SHILPAMED SHILPAMED — Smart-Money Activity, F&O Buildup & Bulk Deals
Sector: UnknownLive setups screens SHILPAMED is on right now — tap to see every stock matching
Smart Money Verdict synthesis of derivatives, deals, and promoter files
Analysis what the data is telling us about SHILPAMED
SHILPAMED did not have meaningful F&O activity in the last completed session. That doesn't mean the stock is irrelevant — it just means the smart-money signals here come from cash markets and corporate disclosures, covered below.
There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in SHILPAMED over the last 30 sessions.
Putting it together, the smart-money picture for SHILPAMED is balanced between accumulation and distribution forces.
F&O Positioning EOD derivatives setup
Quote Details key metrics & weights
Technical Snapshot from 250 sessions of price history
Key Fundamentals headline ratios · Healthcare
Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.
Institutional Deals last 30 sessions (bulk & block)
| Date | Side | Price | Value (Cr) | Counterparty |
|---|---|---|---|---|
| 2026-08-06 | SELL | ₹ 760.04 | 81.89 | MICROCURVES TRADING PRIVATE LIMITED |
| 2026-08-06 | BUY | ₹ 759.36 | 81.82 | MICROCURVES TRADING PRIVATE LIMITED |
| 2026-08-05 | SELL | ₹ 723.16 | 79.77 | MICROCURVES TRADING PRIVATE LIMITED |
| 2026-08-05 | BUY | ₹ 722.79 | 79.73 | MICROCURVES TRADING PRIVATE LIMITED |
Insider & Promoter Filings last 60 days
Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others
SHILPAMED — frequently asked questions
What is the SHILPAMED share price today?
SHILPAMED is trading at ₹759.75 (+2.84% vs previous close), per the latest update on this page.
What is the P/E ratio of SHILPAMED?
SHILPAMED (SHILPAMED) has a trailing twelve-month P/E ratio of 59.5.
What is the market cap of SHILPAMED?
SHILPAMED has a market capitalisation of approximately ₹14,859 crore.
Is SHILPAMED near its 52-week high?
SHILPAMED is trading -3.4% from its 52-week high of ₹786.15.
What is the RSI of SHILPAMED?
The 14-day RSI of SHILPAMED is 79.1, which is considered overbought.
Is SHILPAMED above its 200-day moving average?
SHILPAMED is trading above its 200-DMA of ₹417.67 (+81.9% away).
Are FIIs or big investors buying SHILPAMED?
Strota tracks every bulk and block deal in SHILPAMED with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.